Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I told you this would happen back in 2015. Just 3 days before the FDA rejected Surgiflop. You were lucky to see $6.50 again, nevertheless, I told you to sell both times. I gave detailed clinical reasons why. You ignored it.
Oh yea, I remember that.
Link on that? I was told today that Florida Hospital sent Alf back to Transenterix
Yep. No hospital they’ve sold to provides “Senhance” surgeries.
Call them and ask.
I did.
Training only.
And a tip to you. Learn about counter traction.
Senhance can’t do it,l
Exactly! Who is buying them! Not one single hospital for commercial use. Intuitive never pulled this scam. They invested millions, made no claims and then the hospitals preform clinical studies. Pope announced these as SALES.
Florida Hospital just returned Senhance back to Transenterix. That took a lot longer than I thought
Absolutely not. A commercial sale is strictly a purchase to generate revenue for a hospital. Trxc has been announcing “clinical sales” which are for training purposes.
Can you hear me now?
Not commercially.
A day? Alf was built in 2003!
Alfs original designers for radioactive waste.
Back in 2003.
Think
Alf has yet to get one single commercial sale since it’s CE or FDA approval. It 20 years old.
Think
Yep. I’ll be here too... watching the downfall.
I warned all of em.
Yes they are.
Nothing wrong with refuting blind pumping on a nonviable RASD. As for shorting, I am shorting, since 4.20.
It’s about providing experience in the field to allow current and potential investors make a knowledgeable decision on their investments.
When Davinci can perform a 13 minute TAHBSO and “Senhance” takes 147 minutes the reasons for not investing are obvious.
I’ve told you that ultrasonic energy is decades old. That’s exactly why there was no “pop” today. Davinci has had a better device for the last 3 years and they now manufacture it in house (unlike the decades old ultrasonic pope is pumping) As usual, I’ll prove the study.. the device? Vessel sealer. I’ve told you that ultrasonic energy is decades old. That’s exactly why there was no “pop” today. Davinci has had a better device for the last 3 years and they now manufacture it in house (unlike the decades old ultrasonic pope is pumping) As usual, I’ll prove the study..
https://www.omicsonline.org/bipolar-vessel-sealer-versus-harmonic-scalpel-in-laparoscopic-supracervical-hysterectomy-2161-0932.1000137.php?aid=10469
Less
ZERO “Probability” of “acquisition. Why in the hell do people with zero education in the OR opine to a surgical device when they don’t even know what aseptic technique is?
Amazing.
Somebody needs attention. That email must be hard!
What amazing is that we are beating the national average by 8% over the last 2 quarters and now have a 3rd Xi on the way this month.
Experience in the OR is ABSOLUTELY relevant, otherwise you’re stuck “going with the doc” without knowing what’s opined to have merit.
The conversion rate for Davinci is less than 1%, that alone speaks volumes.
Added 2K shares @ $2.86 at the open
The problem with Titan is that Intuitive has too much of a footprint and VERB is addressing image guidance.
Does Titan?
Intuitive has been working on that for the last 5 years and still have major headway on VERB.
LMFAO
Ask naysayers what they know about surgical devices and technique.
They know NOTHING.
No. That’s NOT “all you have to do”. Ever been in a OR?
Not one single medical device has not had issues and the MAJORITY lie with the surgeons that are not properly trained on the procedure or device.
Here is one study and I can guarantee that the rest are no better. https://www.ncbi.nlm.nih.gov/pubmed/27247263
Search for yourself. Transenterix.com/clinical
The premise is simple. It takes (The renamed ALF-X by Pope) Senhance 147 Minutes to preform a TAHBSO while Laparoscopic Times are averaging 83 minutes. Davinci Times are just 20 minutes and the patient goes home the same day vs 2-3 days post op with Senhance. Patients undergoing Senhance surgeries also experience more post op pain vs Laparoscopic and Davinci procedures.
The “sales” being replanted CLINICl and not commercial.
Senhance is a complete scam orchestrated by Pope.
Yep. Stay away from “analysts” opinions on RASD’s. Most OR staff don’t even understand the complexities of this type of surgical procedure.
Transenterix has one single product, “Senhance” and it is a RASD (Robotic Assisted Surgical Device) that was built by SOFAR in 2009. SOFAR, a Italian pharmaceutical company built this device and named it Telap ALF-X, they are based in Milan, Italy and partnered with a few clinical hospitals in Rome for testing and clinical studies. In 2013, ALF-X received CE clearance in Europe for these trials. From 2013 to 2016 clinical studies were conducted and proved Alf-x was not a viable platform based on Laparoscopic comparison. The clinical data is available at Transenterix own website that redirects to NCBI
Nope. Prostatectomies are still done in open procedures 45% of the time. The rest are RASD (Davinci), no other “machines” assist in prostatectomies.
Um Nope.
Alf Times are not even close to Laparscopic and if you don’t know how RASD procedures are timed (and you don’t) you really shouldn’t be arguing. Davinci tahbso takes 25 minutes.
Instead of a TRXC sponsored Vimeo pump, look at the data sofar Surgeons submitted during clinical trials.
The study titled: Total Laparoscopic (S-LPS) versus TELELAP ALF-X robotic-assisted hysterectomy: a case-control study
The results of this study were similar to the previous one. It was published in October 2016. For the ALF-X group, the median operative time was 147 minutes. For the standard laparoscopic group, the median operative time was 80 minutes. Procedures were performed without conversion in 94.3% of cases in the ALF-X group, and in all cases in the standard laparoscopic group. Again, conversions were only needed in the ALF-X group.
Early postoperative pain was significantly lower in the standard laparoscopic group. This makes sense, as the ALF-X causes more pain since it's a longer surgery, the Senhance instruments in a patient's body are ripping up more tissues and organs
You have no clue how RASD platforms work.
You have no clue that Alf isn’t viable.
The clinical data is available.
Exposure? LOL! SafeStitch?! That’s Popes legacy after all. Tod Pope has yet to produce a single product that’s made a dime in the last 20 years!
Ask J&J, they fired him.
Transenterix will be bankrupt in one year. They have a 10 year old RASD that is OBSOLETE. EOM.
Once again, I’ve done more dd on Transenterix then you’ll ever do. Anything I ask you is rhetorical.
Then post the link.
Wow, you can’t address the premise of Alf being nonviable.
Too bad you didn’t short from $4.68.
Transenterix will never see it again.
Next stop...
Sub buck next year.
Never shorted a stock in 25 years of trading. Thanks to disparage comments and uneducated TRXC pumpers assaulting me ... I finally did, and I made BANK. I learned how to short because dumb assess couldn’t address facts but instead chose to attack me.
Comments from lonely people are only strengthening my opinion. When Transenterix goes bankrupt (and it will) the uneducated pumpers will go “poof”.
I’ll still be here.